Researchers Attend MS Milan 2023

Wednesday, October 18, 2023

Last week, our scientist attended #MSMilan2023. The event was jointly hosted by #Ectrims & #Actrims and gathered MS experts from across the globe to meet and discuss some of the groundbreaking MS news and research.

Our team shared and present 5 different topics: 

  • PAK1 and E2F1 dysregulation induces a p21-mediated defect of oligodendrocyte differentiation in a cerebral organoids model of multiple sclerosis
  • In vitro infection of CNS-derived cells with Epstein-Barr virus using a B-cell transfer method
  • Pathogenic cerebrospinal fluid antibodies in oligoclonal band-negative primary progressive MS patients
  • Intrathecal Cell Therapy is Associated with a Reduction in Inflammatory Biomarkers in Cerebrospinal Fluid of Progressive MS Patients 
  • Investigation of cerebrospinal fluid antibody specificity in primary progressive MS


News Archive


Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy


Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.